Clinical Trials Logo

Filter by:
NCT ID: NCT05676528 Completed - Neck Pain Clinical Trials

Exercise Intervention for Employees of the University of Bern

WeMoveVirtual
Start date: October 1, 2022
Phase: N/A
Study type: Interventional

As part of a Swiss National Science Foundation SNSF project (On-site multi-component intervention to improve productivity and reduce the economic and personal burden of neck pain in Swiss Office-Workers, NEXpro = Neck EXercises for productivity, SNSF no. 32003B_182389, BASEC no. 2019-01678), the investigators first developed a physiotherapeutic exercise intervention to improve the strength and mobility of the neck muscles. In the SNSF project NEXpro, the intervention took place on-site in the office. However, in view of the digital transformation, it is important to adapt the intervention delivery method to the new virtual work setting. The aims of the present project are therefore to implement, further develop and contextually adapt the exercise intervention in order to reduce musculoskeletal complaints and to reduce health-related presenteeism. The final product is a user-friendly virtual 6-week short exercise intervention that employees of the University of Bern can use independently, regardless of time and place. The effectiveness of the newly developed short exercise intervention (pain reduction, reduction of presenteeism) will be assessed during a short pilot phase.

NCT ID: NCT05676268 Recruiting - Peri-Implantitis Clinical Trials

Implant-supported Fixed Dental Prostheses (FDPs) With Cantilever Extension

Start date: January 2, 2023
Phase:
Study type: Observational

To report the clinical and radiographic outcomes of implant-supported fixed dental prostheses with full-ceramic cantilever extensions (FDPCs) after a function time ≥ 12 months.

NCT ID: NCT05674630 Recruiting - Clinical trials for Chronic Coronary Syndrome

Ticin for the Treatment of Coronary Lesions With Drug Eluting Ballons

TITAN-DEB
Start date: February 21, 2023
Phase: Phase 4
Study type: Interventional

The goal of this clinical trial is to compare the use of a specific drug eluting balloon (Magic Touch, Concept Medical®) versus standard drug eluting stent based strategies in patients with long coronary lesions. Participants with chronic coronary disease and long coronary stenosis will be randomly assign to be treated either with Magic Touch balloon or drug eluting stent.

NCT ID: NCT05674058 Recruiting - Stargardt Disease Clinical Trials

Function and Imaging Assessments for G1961E-associated Stargardt Disease

FIRSTORBIT
Start date: November 1, 2022
Phase:
Study type: Observational

Some phenotypes of Stargardt disease are rather distinct. This includes the 'bull's eye maculopathy' phenotype associated with the frequent ABCA4 G1961E variant. In anticipation of a treatment trial, this natural history study aims to compare functional and structural outcome measures systematically.

NCT ID: NCT05673057 Recruiting - Leukemia Clinical Trials

Study of MP0533 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Start date: December 29, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability, and preliminary activity of MP0533 in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)

NCT ID: NCT05672329 Completed - Anesthesia Clinical Trials

Functional Residual Capacity Under Apnoeic Oxygenation With Different Flow Rates in Children

FUTURE
Start date: January 9, 2023
Phase: N/A
Study type: Interventional

During induction of general anaesthesia physiological breathing stops and needs to be artificially established with facemask ventilation, and finally tracheal intubation or placement of a supraglottic airway. During the airway management, when lungs are not or only poorly ventilated, there is a risk for atelectasis. These atelectasis can contribute to respiratory adverse events (e.g. pulmonary infection or respiratory insufficiency) during or after general anaesthesia. High-flow nasal oxygen (HFNO) is the administration of heated, humidified and blended air/oxygen mixture via a nasal cannula at rates ≥ 2 L/kg/min. HFNO used during airway management (i.e. intubation) can extend the tolerance for apnea, the time from end of physiological breathing until artificial ventilation is established. The main objective of this study is thus to investigate the variations of poorly ventilated lung units (i.e., silent spaces) as a surrogate for functional residual capacity measured by electrical impedance tomography to dynamically assess atelectasis formation and regression under apnoeic oxygenation with different flow rates.

NCT ID: NCT05672199 Recruiting - Ulcerative Colitis Clinical Trials

Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

Start date: April 28, 2023
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the long-term safety and tolerability of efavaleukin alfa in participants with moderate to severe ulcerative colitis (UC).

NCT ID: NCT05671965 Active, not recruiting - Appetite Clinical Trials

Effects of Oral Xylitol on Subsequent Energy Intake

Start date: January 27, 2023
Phase: N/A
Study type: Interventional

The aim of this project is to investigate the effect of xylitol (given as pre-load), compared to sucrose, Ace-K, and water on energy intake during a subsequent ad libitum test meal in healthy participants. Furthermore, the release of GI hormones, glycemic control, appetite-related sensations, GI tolerance, sweetness and liking in response to the pre-loads will be investigated.

NCT ID: NCT05671679 Active, not recruiting - Type 1 Diabetes Clinical Trials

Supporting Meal Management in Type 1 Diabetes

SUMMIT1
Start date: March 27, 2023
Phase: N/A
Study type: Interventional

Carbohydrate count marks the cornerstone of Type 1 Diabetes management. Eventhough it is a crucial task, it is burdensome and prone to error. Therefore, the investigators want to explore the effect that SNAQ, a food analyser app would have in glycaemic control by facilitating the task of carbohydrate estimation.

NCT ID: NCT05671666 Recruiting - Clinical trials for Urea Cycle Disorders

Ureagenesis Analysis in Healthy Subjects and in Urea Cycle Disorder Patients

Start date: October 31, 2019
Phase: N/A
Study type: Interventional

Urea cycle disorders (UCDs) are dramatic congenital inherited metabolic disorders. There is no cure. Many novel therapeutic approaches are currently being developed, which hopefully will change the current situation. Testing the efficacy of such new therapies in patients is a challenge, because many clinical parameters are influenced by several disturbances and biochemical parameters are often not very specific. The measurement of ureagenesis is a tool to analyze the entire function of the urea cycle in a single test. This is more meaningful for the characterization of UCD patients than the analysis of single metabolites or enzymes. Therefore, the test will be important to evaluate current and future novel therapies. The term "ureagenesis" means "production of urea", which is the main task of the urea cycle. This total urea production can be measured with a "tracer" (in this case a stable ammonium chloride isotope). This tracer is non-radioactive and non-toxic. It is for example used as an unmarked substance in cough syrup, diuretic drugs and as food additive. Thus, the tracer does not pose a risk to the participant, especially since only a very low dose is applied. The investigators will analyze specific substances from the urea cycle (namely [15N, 14N] urea and several [15N] amino acids) that are produced during the test and compare them with results from healthy people. The maximum test duration is 5 hours. This project is being carried out at one site, namely the University Children's Hospital in Zurich. This project is being carried out under Swiss law. The responsible Ethics Committee has reviewed and approved the study.